Nuvectis Pharma, Inc. (NVCT)
NASDAQ: NVCT · Real-Time Price · USD
8.53
+0.10 (1.19%)
May 14, 2025, 9:30 AM - Market open

Nuvectis Pharma Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
May '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Market Capitalization
202105145110--
Market Cap Growth
56.85%-27.66%31.58%---
Enterprise Value
1698712286--
Last Close Price
8.435.418.347.50--
PB Ratio
9.5110.7611.847.72--
P/TBV Ratio
9.5110.7611.847.72--
Quick Ratio
3.252.082.743.232.37-
Current Ratio
3.282.092.753.302.41-
Return on Equity (ROE)
-115.28%-173.41%-168.51%-206.81%-609.74%-
Return on Assets (ROA)
-52.69%-65.64%-69.14%-83.30%--
Return on Capital (ROIC)
-75.12%-113.21%-103.60%-122.13%-171.30%-
Earnings Yield
-10.12%-18.18%-15.40%-17.38%--
Buyback Yield / Dilution
-12.13%-10.01%-22.90%-196.55%-9.44%-
Updated Feb 25, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q